Primary Care for HIV-Infected Patients in Resource-Limited Settings

  • Authors: Charles van der Horst, MD; F. Parker Hudson, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • Patients unable to tolerate adverse effects require ART modification (Table 7)
  • Stavudine is associated with toxicities such as lipodystrophy, metabolic syndrome, lactic acidosis, pancreatitis, and peripheral neuropathy, and should no longer be used in first-line ART regimens[WHO ART]

Action required